Search Within

Maria Michelle Rubinstein

Formats
  1. Journal Article (19)
  2. Meeting Abstract (13)
  3. Review (3)
Groups
  1. GDMT, Medicine (35)
  2. Gynecologic Medicine Service (35)
  3. Gynecology Disease Management Team (35)
  4. Solid Tumor Oncology Division (35)
  5. Weinberg Fellows (35)
  6. Department of Medicine (31)

More Groups

People
  1. Vicky Makker (26)
  2. Carol Aghajanian (20)
  3. Alexia Iasonos (14)
  4. Rachel Grisham (14)
  5. Claire Friedman (13)
  6. Britta Weigelt (12)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Gynecologic Oncology (13)
  2. International Journal of Gynecological Cancer (4)
  3. Journal of Clinical Oncology (4)
  4. Gynecologic Oncology Reports (3)
  5. Annals of Oncology (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (14)
  2. Lippincott Williams & Wilkins (6)
  3. American Society of Clinical Oncology (4)
  4. Elsevier B.V. (3)
  5. American Association for Cancer Research (2)
  6. Nature Publishing Group (2)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Novel androgen receptor splice variant 7 in gynecologic tumors
    Journal Article

    Wang, L.; Vasudevaraja, V.; Tran, I.; Sukhadia, P.; Reuter, V. E.; Abu-Rustum, N. R.; Rubinstein, M. M.; Gopalan, A.; Ross, D.; Snuderl, M.; more...
    International Journal of Gynecological Pathology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and tumor mutational burden are associated with higher microbiome diversity in the reproductive tract
    Meeting Abstract

    Rubinstein, M.; Gradissimo, A.; Taur, Y.; Varice, N.; Roche, K. L.; Broach, V.; Leitao, M.; Sonoda, Y.; Weigelt, B.; Zivanovic, O.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • DB-1305 (a Trop-2 targeted antibody-drug-conjugate [ADC]) in patients (pts) with advanced solid tumors: Preliminary clinical results from the phase (Ph) I/IIa study
    Meeting Abstract

    Marathe, O.; Cheng, Y.; Spira, A. I.; Hamilton, E. P.; Rubinstein, M. M.; Dong, X.; Li, L.; Lv, D.; Shi, J.; Gabrail, N.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save